Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
57.00
-0.25 (-0.44%)
Feb 21, 2025, 4:00 PM EST - Market closed
Belite Bio Employees
Belite Bio had 20 employees as of December 31, 2023. The number of employees increased by 4 or 25.00% compared to the previous year.
Employees
20
Change (1Y)
4
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,651,700
Market Cap
1.76B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 20 | 4 | 25.00% |
| Dec 31, 2022 | 16 | 4 | 33.33% |
| Dec 31, 2021 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
BLTE News
- 17 days ago - Belite Bio Announces Registered Direct Offering of $15 Million - GlobeNewsWire
- 3 months ago - Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007 - GlobeNewsWire
- 3 months ago - Belite Bio, Inc. (BLTE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds - GlobeNewsWire
- 6 months ago - Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer - GlobeNewsWire
- 6 months ago - Belite Bio, Inc (BLTE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire